The difference with the stem cell stocks is that there has not been a run up in anticipation of a successful trial.In fact our market cap has gone from 3 billion to one billion in the last time 5 years.
When big money knows a drug will fail they run the price up to dump the shares. Here they keep the price down because they know all these trials are successful
MSB Price at posting:
$2.49 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)